Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.
The American journal of drug and alcohol abuse January 1, 2018 Geoffrey E Noller, Chris M Frampton, Berra Yazar-Klosinski 150 citations
A single ibogaine treatment reduced opioid withdrawal symptoms and led to opioid cessation or sustained reduced use over 12 months in dependent individuals. Among 14 participants (50% female) receiving legal ibogaine treatment in New Zealand, addiction severity scores dropped significantly from baseline to 12-month follow-up for the 8 who completed all interviews. Depression scores also significantly decreased. Opioid withdrawal symptoms fell acutely after treatment for all 14 participants. One patient died during treatment. Legal availability in New Zealand may improve outcomes by allowing treatment providers to collaborate with other health professionals.